1.
Marushko YY, Mankovsky GB, Levadska AA. Inclisiran Usage in Very High-Risk Patients with Dyslipidemia Resistant to Statins and Ezetimibe Therapy. ujcvs [Internet]. 2024Jun.27 [cited 2024Jul.18];32(2):33-7. Available from: http://cvs.org.ua/index.php/ujcvs/article/view/644